Discuss This Drug

Brivaracetam

CHEBI:CHEBI_133013

Definition

A non-proteinogenic amino acid derivative that is butanamide in which the pro-S hydrogen at position 2 is replaced by a (4R)-2-oxo-4-propylpyrrolidin-1-yl. Used for treatment of partial onset seizures related to epilepsy.

Chemical Information

Molecular Formula
C11H20N2O2
Molecular Mass
212.289
Charge
0
SMILES
N1([C@H](C(N)=O)CC)C(C[C@H](C1)CCC)=O
InChI
InChI=1S/C11H20N2O2/c1-3-5-8-6-10(14)13(7-8)9(4-2)11(12)15/h8-9H,3-7H2,1-2H3,(H2,12,15)/t8-,9+/m1/s1
InChIKey
MSYKRHVOOPPJKU-BDAKNGLRSA-N

Alternative Names

  • (2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide
  • 2-(2-Oxo-4-propylpyrrolidin-1-yl)butanamide
  • brivaracetam
  • Briviact
  • UCB 34714
  • UCB34714

Treatment Applications

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
1739745
oboInOwl#hasDbXref
Wikipedia:Brivaracetam
core#notation
CHEBI:133013

Additional References

Wikipedia:Brivaracetam

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
1739745
generic_name
BRIVARACETAM
brand_name
Briviact
brand_name_base
Briviact
oboInOwl#hasDbXref
Wikipedia:Brivaracetam
oboInOwl#id
CHEBI:133013
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
INJECTION, SUSPENSION
marketing_start_date
20240128
labeler_name
Lee Pharma Limited
product_ndc
16812-009
application_number
NDA205837
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_35623
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
chebi#has_functional_parent
http://purl.obolibrary.org/obo/CHEBI_35619
core#notation
CHEBI:133013
rxcui
1739788
dea_schedule
CV
active_ingredient_strength
50 kg/50kg
active_ingredient_name
BRIVARACETAM
package_marketing_start_date
26-MAY-15
manufacturer_name
UCB, Inc.
unii
U863JGG2IA
spl_set_id
3cf2f439-0e97-443e-8e33-25ecef616f6c
nui
N0000192345
pharm_class_moa
Epoxide Hydrolase Inhibitors [MoA]
pharm_class
Epoxide Hydrolase Inhibitors [MoA]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
route
INTRAVENOUS
spl_id
0ea1e398-f858-3fef-e063-6394a90a867e
package_ndc
16812-009-01
package_description
1 BAG in 1 DRUM (16812-009-01) / 25 kg in 1 BAG
has_treatment
http://purl.obolibrary.org/obo/DOID_2234
rdf-schema#range
https://w3id.org/def/predibionto#has_drug_106632
owl#annotatedSource
t100687
owl#someValuesFrom
t2994889